Mohammad Alhomoud and Joshua Fein

Chimerically Speaking

Health EN ↓ 7 episodes

Chimerically Speaking is the podcast where we explore latest and greatest in the world of transplantation and cellular therapy. Hosts Mohammad Alhomoud and Joshua Fein discuss recent studies and invite leaders and creative minds from aross the field to learn about their work, their ideas, and how they arrived at them. Hosted on Acast. See acast.com/privacy for more information.

Be sure to visit the podcast's website and support the creator: shows.acast.com

Author

Mohammad Alhomoud and Joshua Fein

Category

Health

Podcast website

shows.acast.com

Latest episode

Sep 9, 2024

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 10M+ downloads · 4.7+ rating iOS soon

Episodes

Season 2 premiere! CLL and Richter's Transformation with Dr. Adam Kittai 09.09.2024

Dr. Adam Kittai joins us to discuss the role for cellular therapy and allogeneic transplantation in the treatment of chronic lymphocytic leukemia and Richter's transformation. We discuss his recent publication in JCO "Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation", the approval of liso-cel for CLL, and more! Hosted on Acast. See acast.com/privacy for more informatio...

Episode 6 - Thinking Meta about CAR Mortality with David Cordas dos Santos and Kai Rejeski 22.07.2024

We chat with David Cordas dos Santos and Kai Rejeski, first and last author of a major new article in Nature Medicine: A Systematic Review and Metaanalysis of Nonrelapse Mortality after CAR T Cell Therapy . Hosted on Acast. See acast.com/privacy for more information.

Episode 5 - Transplant Strikes Back... immediately! The ASAP trial takes on active disease 28.05.2024

We were delighted to speak with Dr. Arjun Law (Princess Margaret Cancer Center, Toronto, ON) about the ASAP trial https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(24)00065-6/fulltext (Stelljes, Middeke, Bug et al., Lancet Haem 2024) and his thoughtful commentary https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(24)00072-3/fulltext (Law, Mattsson, Lancet Haem 2024). Hos...

To p(53) or not to p(53): interview with Dr. Mariam Nawas 24.04.2024

What a delight to have Dr. Mariam Nawas of the University of Chicago join us for a round-up of her favorite abstracts from Tandem 2024! We also discussed her recent and controversial review " Utility or futility? A contemporary approach to allogeneic hematopoietic cell transplantation for TP53-mutated MDS/AML ", which appeared in Blood Advances earlier this year. Hosted on Acast. See acast.com/pri...

CARpe diem! Lymphoma CAR-T roundup with Dr. Sam Yamshon 01.04.2024

Dr. Sam Yamshon, assistant professor of medicine at Weill Cornell Medicine at New York Presbyterian, joins us to chat about the most thought-provoking lymphoma CAR-T abstracts from #Tandem24. Hosted on Acast. See acast.com/privacy for more information.

ICAHT Take It Anymore! 11.03.2024

We're joined 'in the studio' by our very first interview guest, our good friend, the brilliant Dr. Kai Rejeski. Kai has been at the forefront of understanding hematologic toxicity of CAR-T therapies, and speaks with us about the HEMATOTOX score, ICAHT guidelines, and the excellent coffee in San Antonio. Hosted on Acast. See acast.com/privacy for more information.

Episode 1! Off to Tandem 24 19.02.2024

Welcome! This is the first episode of Chimerically Speaking. We're excited to share our love for the science and brilliant, creative community of transplantation and cellular therapy. In this episode we'll talk about the upcoming Tandem 2024 meeting ahead of traveling to San Antonio this week. We highlight two abstracts (of so many!) that really caught our attention: Al Malki and colleages, TSC-10...

Listen to the Chimerically Speaking podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.